SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (7488)12/12/2002 5:05:16 PM
From: Elmer  Respond to of 52153
 
This GILD convert is only about 3 days worth of hedge related short selling.
NEW YORK (Reuters) - Shares of Gilead Sciences (NasdaqNM:GILD - News) sagged in extended trading on Thursday after the biotechnology company said it plans to raise about $300 million through an offering of five-year notes that are convertible into shares of Gilead common stock.